Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Recommendation of “Buy” by Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has earned a consensus recommendation of “Buy” from the nine analysts that are currently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $29.11.

A number of equities analysts recently commented on ASPN shares. Roth Mkm dropped their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. HC Wainwright reissued a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Piper Sandler lowered their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Finally, Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday.

Aspen Aerogels Price Performance

ASPN stock opened at $12.73 on Monday. Aspen Aerogels has a 12 month low of $10.75 and a 12 month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average price of $13.47 and a 200 day moving average price of $20.18. The stock has a market cap of $1.04 billion, a PE ratio of 1,273.77 and a beta of 2.14.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ASPN. Victory Capital Management Inc. acquired a new position in Aspen Aerogels during the 2nd quarter valued at approximately $230,000. Dimensional Fund Advisors LP increased its stake in shares of Aspen Aerogels by 21.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock worth $32,790,000 after acquiring an additional 240,921 shares during the period. Renaissance Technologies LLC acquired a new stake in shares of Aspen Aerogels in the second quarter worth $8,340,000. Hsbc Holdings PLC acquired a new stake in shares of Aspen Aerogels in the second quarter worth $732,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in shares of Aspen Aerogels in the second quarter worth $145,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.